XML 37 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIENCY) - USD ($)
Series A Preferred
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2017 510,000 122,049,958      
Beginning Balance, Amount at Dec. 31, 2017 $ 5,100 $ 1,220,499 $ 42,139,675 $ (37,971,049) $ 5,394,225
Equity based compensation     31,522   31,522
Common stock issued for services provided, Shares   362,500      
Common stock issued for services provided, Amount   $ 3,625 33,875   37,500
Conversion of Notes Payable and Accrued Interest into Common Stock, Shares   1,877,960      
Conversion of Notes Payable and Accrued Interest into Common Stock, Amount   $ 18,780 686,432   705,212
Induced Conversion Costs     57,201   57,201
Net Loss       (3,230,462) (3,230,462)
Ending Balance, Shares at Dec. 31, 2018 510,000 124,290,418      
Ending Balance, Amount at Dec. 31, 2018 $ 5,100 $ 1,242,904 42,948,705 (41,201,511) 2,995,198
Equity based compensation     146,878   146,878
Common stock issued for services provided, Shares   410,000      
Common stock issued for services provided, Amount   $ 4,100 41,100   45,200
Induced Conversion Costs         0
Net Loss       (2,297,733) (2,297,733)
Ending Balance, Shares at Dec. 31, 2019 510,000 124,700,418      
Ending Balance, Amount at Dec. 31, 2019 $ 5,100 $ 1,247,004 $ 43,136,683 $ (43,499,243) $ 889,543